Healthcare -
Drug Manufacturers - General - NYSE - US
$ 97.92
-2.76 %
$ 248 B
Market Cap
20.36
P/E
MRK - STOCK-BASED COMPENSATION
Stock-based Compensation MRK - Merck & Co., Inc.
645 M
LAST VALUE
16.04%
2 YEAR CAGR
13.13%
5 YEAR CAGR
8.86%
10 YEAR CAGR